Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

[ 18 F]-Fludarabine Positron Emission Tomography in Chronic Lymphocytic Leukemia Patients: Results of a Phase I Study

Narinée Hovhannisyan, Sylvain P Chantepie, MD, Meziane Ibazizene, Alain Manrique, MD PhD, Oumedaly Reman, MD, Louisa Barre, Michel Leporrier, MD PhD

Blood (2015) 126 (23): 5267.

https://doi.org/10.1182/blood.V126.23.5267.5267

Published: 2015

Journal Articles

[ 18 F]-Fludarabine Positron Emission Tomography in Diffuse Large B-Cell Lymphoma (DLBCL) Patients: Results of a Phase I Study

Sylvain P Chantepie, MD, Narinée Hovhannisyan, Stéphane Guillouet, Alain Manrique, MD PhD, Oumedaly Reman, MD, Louisa Barre, Michel Leporrier, MD PhD

Blood (2015) 126 (23): 3917.

https://doi.org/10.1182/blood.V126.23.3917.3917

Published: 2015

Journal Articles

Long-Term Outcome of B-CLL Patients Treated in a Prospective Trial Evaluating Combination of Oral Fludarabine and Cyclophosphamide As Frontline Therapy

Romain Guièze, MD, Olivier Tournilhac, MD, PhD, Karim Maloum, MD, PhD, Stéphane Leprêtre, MD, Corinne Haioun, Pierre Feugier, MD, PhD, Alain Delmer, MD, Michel Leporrier, MD, Bruno Cazin, MD

Blood (2011) 118 (21): 1795.

https://doi.org/10.1182/blood.V118.21.1795.1795

Published: 2011

Journal Articles

High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation (ASCT) Has a Significant but Transient Impact on Quality of Life: Lessons From the Chronic Lymphocytic Leukemia (CLL) ASCT Study by the CLL Subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Liesbeth C. de Wreede, PhD, Maggie Watson, Donald Milligan, MD, MBChB, Mauricette Michallet, Peter Dreger, Prof. Dr. med., Marleen van Os, Claire E. Dearden, Catherine Cordonnier, Michel Leporrier, MD, Vladimir Koza, MD, Janis Homewood, Bernadette Corront, MD, Gabriela M. Baerlocher, MD, Wolfgang Herr, Dietger Niederwieser, MD, Laurent Sutton, Theo M. de Witte, MD, Johannes Schetelig, MD

Blood (2011) 118 (21): 1989.

https://doi.org/10.1182/blood.V118.21.1989.1989

Published: 2011

Journal Articles

Consolidation Therapy with Subcutaneous Alemtuzumab After Induction Treatment with Oral FC (Fludarabine and Cyclophosphamide) in Previously Untreated Patients Aged 65–70 Years with Advanced Stage Chronic Lymphocytic Leukemia (CLL): Final Results of a Phase II Study From the FCGCLL/WM,

Alain Delmer, MD, Olivier Tournilhac, MD, PhD, Stéphane Leprêtre, MD, Bruno Cazin, MD, Pierre Feugier, MD, PhD, Brigitte Dreyfus, MD, Beatrice Mahe, Michel Leporrier, MD, Anne-Sophie Michallet, MD, Arnaud Jaccard, Marine Divine, MD, Vincent Levy, MD, Florence Cymbalista, Pr, Remi Letestu, MD

Blood (2011) 118 (21): 3900.

https://doi.org/10.1182/blood.V118.21.3900.3900

Published: 2011

Journal Articles

Autologous stem cell transplantation as a first-line treatment strategy for chronic lymphocytic leukemia: a multicenter, randomized, controlled trial from the SFGM-TC and GFLLC

Blood (2011) 117 (23): 6109–6119.

https://doi.org/10.1182/blood-2010-11-317073

Published: 2011

Journal Articles

Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observation

Mauricette Michallet, Peter Dreger, Laurent Sutton, Ronald Brand, Sue Richards, Marleen van Os, Mohamad Sobh, Sylvain Choquet, Bernadette Corront, Claire Dearden, Alois Gratwohl, Wolfgang Herr, Daniel Catovsky, Michael Hallek, Theo de Witte, Dietger Niederwieser, Michel Leporrier, Donald Milligan

Blood (2011) 117 (5): 1516–1521.

https://doi.org/10.1182/blood-2010-09-308775

Published: 2011

Journal Articles

Expression of the Chemokine Receptor CXCR4, CXCL12G801A Gene polymorphism and SDF1 Plasma Levels in B-Cell Chronic Lymphocytic Leukemia (B-CLL): Correlation with PBSC Mobilisation, Disease Characteristics and Outcome.

Adriana Plesa, MD, Gaetan Lesca, MD, Nathalie Dhedin, MD, Mohamad Sobh, Pharm.M, Anne S. Michallet, MD, PhD, Franck E. Nicolini, MD, PhD, Helene Merle-Beral, MD, PhD, Frederic Garban, MD, Veronique Leblond, MD, Karen Sagorny, Stephane Morisset, Alain Calender, MD, PhD, Charles Dumontet, MD, PhD, Michel Leporrier, MD, Laurent Sutton, MD, Mauricette Michallet, MD, PhD

Blood (2009) 114 (22): 2336.

https://doi.org/10.1182/blood.V114.22.2336.2336

Published: 2009

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation (autoHSCT) in CLL: First Results of An EBMT Randomized Trial Comparing Autotransplant Versus Wait and Watch.

Mauricette Michallet, MD, PhD, Peter Dreger, MD, PhD, Laurent Sutton, MD, Ronald Brand, Sue Richards, Anja van Biezen, Mohamad Sobh, Pharm.M, Alois Gratwohl, MD, Karin Kolbe, MD, Claire E. Dearden, MD, Michael Hallek, T. M. de Witte, MD, PhD, Dietger W. Niederwieser, MD, Michel Leporrier, MD, Donald Milligan, MD

Blood (2009) 114 (22): 877.

https://doi.org/10.1182/blood.V114.22.877.877

Published: 2009

Journal Articles

Autologous Stem Cell Transplantation (ASCT) in CLL. Results of a Phase III Randomized Multicenter Trial.

Blood (2009) 114 (22): 878.

https://doi.org/10.1182/blood.V114.22.878.878

Published: 2009

Journal Articles

ZAP-70 Intron-1 DNA Methylation Status: A Simplified Method of Determination by Pyrosequencing in B Chronic Lymphocytic Leukemia.

Sylvain Chantepie, MD, Dominique Vaur, MD, Christophe Grunau, PhD, Veronique Salaun, MD, Melanie Briand, Stéphane Cheze, MD, Pascal Gauduchon, PhD, Michel Leporrier, MD, Sophie Krieger, PhD

Blood (2008) 112 (11): 1051.

https://doi.org/10.1182/blood.V112.11.1051.1051

Published: 2008

Journal Articles

Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study

Bertrand Godeau, Raphael Porcher, Olivier Fain, François Lefrère, Pierre Fenaux, Stéphane Cheze, Anne Vekhoff, Marie-Paule Chauveheid, Jerôme Stirnemann, Lionel Galicier, Emmanuelle Bourgeois, Stéphanie Haiat, Bruno Varet, Michel Leporrier, Thomas Papo, Mehdi Khellaf, Marc Michel, Philippe Bierling

Blood (2008) 112 (4): 999–1004.

https://doi.org/10.1182/blood-2008-01-131029

Published: 2008

Journal Articles

Consolidation Therapy with Subcutaneous Alemtuzumab Following Induction Treatment with Oral FC (Fludarabine and Cyclophosphamide) in Previously Untreated Patients Aged 65-70 Years with Advanced Stage Chronic Lymphocytic Leukemia (CLL): A Phase II Trial of the FCGCLL/MW.

Alain Delmer, MD, Stéphane Leprêtre, MD, Bruno Cazin, MD, Pierre Feugier, MD, PhD, Olivier Tournilhac, MD, PhD, Michel Leporrier, MD, Brigitte Dreyfus, MD, Béatrice Mahé, MD, Catherine Thieblemont, MD, PhD, Marine Divine, MD, Vincent Lévy, MD, PhD, Véronique Leblond, MD, Florence Cymbalista, MD, PhD, Rémy Letestu, MD, PhD

Blood (2006) 108 (11): 2831.

https://doi.org/10.1182/blood.V108.11.2831.2831

Published: 2006

Journal Articles

Rituximab Is an Alternative to Splenectomy in Adults with Chronic Immune Thrombocytopenic Purpura: Results of a Multicenter Prospective Phase 2 Study.

Bertrand Godeau, MD, Olivier Fain, MD, Raphael Porcher, MD, PhD, Francois Lefrere, MD, Pierre Fenaux, MD, PhD, Stephane Cheze, MD, Anne Vekhoff, MD, Marie-Paule Chauveheid, MD, Jerome Stirnemann, MD, Lionel Galicier, MD, Emmanuelle Bourgeois, MD, Stephanie Haiat, MD, Bruno Varet, MD, Michel Leporrier, MD, Thomas Papo, MD, Marc Michel, MD, Philippe Bierling, MD, PhD

Blood (2006) 108 (11): 478.

https://doi.org/10.1182/blood.V108.11.478.478

Published: 2006

Journal Articles

Impaired Mobilization of Peripheral Blood Stem Cell (PBSC) after Fludarabine Treatment: Comparison of Results Using 3 Different Procedures.

Philippe Genet, MD, Philippe Travade, MD, Bruno Cazin, MD, Stephane Lepretre, MD, Marine Divine, MD, Claude Martin, MD, Veronique Leblond, MD, Eric Van Den Neste, MD, Frederic Maloisel, MD, Mauricette Michallet, MD, Houchingue Eghbali, MD, Christian Berthou, MD, Alain Delmer, MD, Bernard Grosbois, MD, Pierre Feugier, MD, Michel Leporrier, MD, Laurent Sutton, MD, Olivier Tournilhac, MD

Blood (2005) 106 (11): 1978.

https://doi.org/10.1182/blood.V106.11.1978.1978

Published: 2005

Journal Articles

Autologous Stem Cell Transplantation (ASCT) Versus Standard Treatments for CLL Patients: First Interim Analysis of a Prospective Randomized Study from the French Cooperative Study Group on CLL.

Blood (2005) 106 (11): 5471.

https://doi.org/10.1182/blood.V106.11.5471.5471

Published: 2005

Journal Articles

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients

Michel Leporrier, Sylvie Chevret, Bruno Cazin, Najda Boudjerra, Pierre Feugier, Bernard Desablens, Marie-José Rapp, Jerome Jaubert, Claudie Autrand, Marine Divine, Brigitte Dreyfus, Karim Maloum, Philippe Travade, Guillaume Dighiero, Jacques-Louis Binet, Claude Chastang

Blood (2001) 98 (8): 2319–2325.

https://doi.org/10.1182/blood.V98.8.2319

Published: 2001

Journal Articles

A New Case of Chronic Myeloid Leukemia With c3/a2 BCR/ABL Junction. Is It Really a Distinct Disease?

Margaret Macro, Michel Leporrier, Hervé Mittre, Pierre Leymarie

Blood (1997) 89 (11): 4239–4240.

https://doi.org/10.1182/blood.V89.11.4239

Published: 1997

NARROW

[ 18 F]-Fludarabine Positron Emission Tomography in Chronic Lymphocytic Leukemia Patients: Results of a Phase I Study

[ 18 F]-Fludarabine Positron Emission Tomography in Diffuse Large B-Cell Lymphoma (DLBCL) Patients: Results of a Phase I Study

Long-Term Outcome of B-CLL Patients Treated in a Prospective Trial Evaluating Combination of Oral Fludarabine and Cyclophosphamide As Frontline Therapy

Consolidation Therapy with Subcutaneous Alemtuzumab After Induction Treatment with Oral FC (Fludarabine and Cyclophosphamide) in Previously Untreated Patients Aged 65–70 Years with Advanced Stage Chronic Lymphocytic Leukemia (CLL): Final Results of a Phase II Study From the FCGCLL/WM,

Autologous stem cell transplantation as a first-line treatment strategy for chronic lymphocytic leukemia: a multicenter, randomized, controlled trial from the SFGM-TC and GFLLC

Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observation

Expression of the Chemokine Receptor CXCR4, CXCL12G801A Gene polymorphism and SDF1 Plasma Levels in B-Cell Chronic Lymphocytic Leukemia (B-CLL): Correlation with PBSC Mobilisation, Disease Characteristics and Outcome.

Autologous Hematopoietic Stem Cell Transplantation (autoHSCT) in CLL: First Results of An EBMT Randomized Trial Comparing Autotransplant Versus Wait and Watch.

Autologous Stem Cell Transplantation (ASCT) in CLL. Results of a Phase III Randomized Multicenter Trial.

ZAP-70 Intron-1 DNA Methylation Status: A Simplified Method of Determination by Pyrosequencing in B Chronic Lymphocytic Leukemia.

Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study

Consolidation Therapy with Subcutaneous Alemtuzumab Following Induction Treatment with Oral FC (Fludarabine and Cyclophosphamide) in Previously Untreated Patients Aged 65-70 Years with Advanced Stage Chronic Lymphocytic Leukemia (CLL): A Phase II Trial of the FCGCLL/MW.

Rituximab Is an Alternative to Splenectomy in Adults with Chronic Immune Thrombocytopenic Purpura: Results of a Multicenter Prospective Phase 2 Study.

Impaired Mobilization of Peripheral Blood Stem Cell (PBSC) after Fludarabine Treatment: Comparison of Results Using 3 Different Procedures.

Autologous Stem Cell Transplantation (ASCT) Versus Standard Treatments for CLL Patients: First Interim Analysis of a Prospective Randomized Study from the French Cooperative Study Group on CLL.

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients

A New Case of Chronic Myeloid Leukemia With c3/a2 BCR/ABL Junction. Is It Really a Distinct Disease?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only